Roche Ebv Molecular Assay

Lab Reagents

Ebv Assay Laboratories manufactures the roche ebv molecular assay reagents distributed by Genprice. The Roche Ebv Molecular Assay reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ebv assay. Other Roche products are available in stock. Specificity: Roche Category: Ebv Group: Molecular Assay

Molecular Assay information

Recombinant EBV Protein
VAng-Lsx0108-inquire inquire Ask for price
Description: EBV, recombinant protein from human cells.

Inactivated EBV Antigen
VAng-Lsx0109-1mL 1 mL
EUR 1360
Description: EBV, natural antigen.

EBV EBNA1 antibody
20-EG46 1 mg
EUR 116
Description: Goat polyclonal EBV EBNA1 antibody

EBV antibody (VCA)
10-E40B 200 ug
EUR 229
Description: Mouse monoclonal EBV antibody (VCA)

EBV EA protein
30-1280 1 mg
EUR 3481
Description: Purified recombinant EBV EA protein

EBV VCA protein
30-1811 1 ml
EUR 381
Description: Purified native EBV VCA gp125 protein

EBV EA protein
30-1920 1 ml
EUR 414
Description: Viral lysate containing a high concentration of EBV antigens, including VCA, EBNA, EA-D and EA-R

EBV EBNA protein
30-AE46 200 ug
EUR 750
Description: Purified recombinant EBV EBNA protein

EBV EA protein
30-AE50 200 ug
EUR 813
Description: Purified recombinant EBV EA protein

EBV EA protein
30R-AE005 100 ug
EUR 327
Description: Purified recombinant EBV EA protein

EBV EBNA1 protein
30R-AE006 100 ug
EUR 241
Description: Purified recombinant EBV EBNA1 protein

EBV p18 protein
30R-AE007 500 ug
EUR 806
Description: Purified recombinant EBV p18 protein

EBV p23 protein
30R-AE008 100 ug
EUR 327
Description: Purified recombinant EBV p23 protein

SARS-CoV-2 Rapid Antigen Test Nasal
9901-NCOV-03G 25 Tests/Kit
EUR 94
Description: The SARS-CoV-2 Rapid Antigen Test is a lateral fl ow rapid chromatographic immunoassay for the qualitative detection of nucleocapsid antigen to SARS-CoV-2 present in human nasal samples. This test is intended for use as an aid in detection of SARS-CoV-2 infection in individuals suspected of COVID-19 with clinical symptoms onset within 5 days. Results are for the identification of SARS-CoV-2 nucleocapsid antigen. Antigen is generally detectable in human nasal swab samples during the acute phase of infection. Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status. Positive results do not rule out bacterial infection or co- infection with other viruses. The agent detected may not be the definite cause of disease. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19, and confirmed with a molecular assay, if necessary, for patient management. The SARS-CoV-2 Rapid Antigen Test is intended for use in laboratory or POC settings by healthcare professionals, or self-collection under the supervision of a healthcare worke

Agarose, Molecular Grade
BIO-41025 500g Ask for price

Agarose, Molecular Grade
BIO-41026 100g Ask for price

Molecular Weight Marker
abx098957-15ul 15 ul
EUR 105